[1] Morré DJ, et al. A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-(methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients. J Bioenerg Biomembr. 1997;29(3):281-289. DOI:
10.1023/a:1022466212083[2] Neubauer BL, et al. Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984. J Urol. 1992;147(2):500-504. DOI:
10.1016/s0022-5347(17)37288-9
